title: [Two new drugs for the treatment of idiopathic lung fibrosis: A new therapeutic era!].
authors.affiliation: Service de pneumologie A, hôpital Bichat, centre de compétence pour les maladies pulmonaires rares, département hospitalo-universitaire FIRE, Inserm U1152, AP-HP, 46, rue Henri-Huchard, 75018 Paris, France. Electronic address: bruno.crestani@aphp.fr.
authors.forename: B
authors.initials: B
authors.lastname: Crestani
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000175:diagnosis / Q000188:drug therapy*; D007211:Indoles / Q000494:pharmacology / Q000627:therapeutic use*; D011728:Pyridones / Q000494:pharmacology / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011728:Pyridones; C093844:pirfenidone; C530716:nintedanib
keywords: Diffuse interstitial pulmonary fibrosis; Fibrose pulmonaire idiopathique; Idiopathic pulmonary fibrosis; Pneumopathie interstitielle commune; Pneumopathie interstitielle diffuse fibrosante; Traitement; Treatment; Usual interstitial pneumonia